Home > Research > Publications & Outputs > Mammographic dysplasia as entry criterion for b...

Research

Links

Text available via DOI:

View graph of relations

Mammographic dysplasia as entry criterion for breast cancer prevention trials

Research output: Contribution to Journal/Magazine › Letter › peer-review

Published

Standard

Mammographic dysplasia as entry criterion for breast cancer prevention trials. / Berridge, Damon; Whitehead, John; Cuzick, Jack.
In: The Lancet, Vol. 337, No. 8751, 18.05.1991, p. 1225.

Research output: Contribution to Journal/Magazine › Letter › peer-review

Harvard

Berridge, D, Whitehead, J & Cuzick, J 1991, 'Mammographic dysplasia as entry criterion for breast cancer prevention trials', The Lancet, vol. 337, no. 8751, pp. 1225. https://doi.org/10.1016/0140-6736(91)92897-B

APA

Berridge, D., Whitehead, J., & Cuzick, J. (1991). Mammographic dysplasia as entry criterion for breast cancer prevention trials. The Lancet, 337(8751), 1225. https://doi.org/10.1016/0140-6736(91)92897-B

Vancouver

Berridge D, Whitehead J, Cuzick J. Mammographic dysplasia as entry criterion for breast cancer prevention trials. The Lancet. 1991 May 18;337(8751):1225. doi: 10.1016/0140-6736(91)92897-B

Author

Berridge, Damon ; Whitehead, John ; Cuzick, Jack. / Mammographic dysplasia as entry criterion for breast cancer prevention trials. In: The Lancet. 1991 ; Vol. 337, No. 8751. pp. 1225.

Bibtex

@article{6eb0e692af2a422792a46aabe7460250,
title = "Mammographic dysplasia as entry criterion for breast cancer prevention trials",
author = "Damon Berridge and John Whitehead and Jack Cuzick",
year = "1991",
month = may,
day = "18",
doi = "10.1016/0140-6736(91)92897-B",
language = "English",
volume = "337",
pages = "1225",
journal = "The Lancet",
issn = "1474-547X",
publisher = "Lancet Publishing Group",
number = "8751",

}

RIS

TY - JOUR

T1 - Mammographic dysplasia as entry criterion for breast cancer prevention trials

AU - Berridge, Damon

AU - Whitehead, John

AU - Cuzick, Jack

PY - 1991/5/18

Y1 - 1991/5/18

U2 - 10.1016/0140-6736(91)92897-B

DO - 10.1016/0140-6736(91)92897-B

M3 - Letter

VL - 337

SP - 1225

JO - The Lancet

JF - The Lancet

SN - 1474-547X

IS - 8751

ER -